https://thevitalrecord.ai/2026/06/12/belzutifan-pembro-adjuvant-rcca-approval/ The Vital Record en 2026-06-12T00:00:00.000Z FDA Approves Belzutifan Plus Pembrolizumab as First Adjuvant Combination Therapy for High-Risk Clear-Cell Renal Cell Carcinoma https://thevitalrecord.ai/2026/06/12/lassa-fever-vaccine-phase1-lassarab/ The Vital Record en 2026-06-12T00:00:00.000Z First-in-Human Lassa Fever Vaccine Reports 100% Seroconversion in Phase 1 Trial https://thevitalrecord.ai/2026/06/12/dmg-brain-network-survival-nature/ The Vital Record en 2026-06-12T00:00:00.000Z Fatal Paediatric Brain Tumours Are Wired Into the Brain — Disrupting That Network May Extend Survival https://thevitalrecord.ai/2026/06/12/artemisinin-resistance-zambia-southwest-africa/ The Vital Record en 2026-06-12T00:00:00.000Z Preliminary Data: Artemisinin-Resistance Mutation Has Swept to 79% in Western Zambia, With Day-3 Positivity 28 Times Higher Than Eastern Zambia https://thevitalrecord.ai/2026/06/12/integrate-iib-regonivo-gej-cancer-phase3/ The Vital Record en 2026-06-12T00:00:00.000Z RegoNivo Fails to Extend Survival in Phase 3 Gastric Cancer Trial, Deflating Early-Phase Enthusiasm https://thevitalrecord.ai/2026/06/12/us-measles-2073-cases-elimination-risk/ The Vital Record en 2026-06-12T00:00:00.000Z U.S. Measles Cases Reach 2,073 Across 40 Jurisdictions — Elimination Status at Risk Before November Review https://thevitalrecord.ai/2026/06/12/jnj-firefly-bio-kras-degrader-acquisition/ The Vital Record en 2026-06-12T00:00:00.000Z J&J to Acquire Firefly Bio for $1 Billion, Gaining Nobel Laureate-Backed KRAS-Targeting Degrader Antibody Conjugate Platform https://thevitalrecord.ai/2026/06/12/cytisinicline-pdufa-june20-smoking-cessation/ The Vital Record en 2026-06-12T00:00:00.000Z FDA Decision Due June 20 on Cytisinicline — First New Smoking-Cessation Drug Since Varenicline in 2006 https://thevitalrecord.ai/2026/06/11/serpina1-base-editing-first-human/ The Vital Record en 2026-06-11T00:00:00.000Z First Human Liver Biopsy Shows 54–57% On-Target Correction of SERPINA1 After In Vivo Base Editing https://thevitalrecord.ai/2026/06/11/skyscraper-15-tigit-terminated/ The Vital Record en 2026-06-11T00:00:00.000Z Roche Terminates Phase 3 SKYSCRAPER-15 Tiragolumab Trial in Resected NSCLC, Deepening TIGIT Setbacks https://thevitalrecord.ai/2026/06/11/bemotrizinol-sunscreen-otc-monograph/ The Vital Record en 2026-06-11T00:00:00.000Z FDA Adds First New Sunscreen Active Ingredient in 25 Years: Bemotrizinol Cleared via CARES Act Monograph Process https://thevitalrecord.ai/2026/06/11/wiser-medicare-ai-prior-auth-defunded/ The Vital Record en 2026-06-11T00:00:00.000Z House Appropriations Panel Votes to Strip Funding from CMS's AI-Powered Medicare Prior-Authorization Pilot https://thevitalrecord.ai/2026/06/11/pevac-pan-sarbecovirus-vaccine-phase1/ The Vital Record en 2026-06-11T00:00:00.000Z AI-Designed Pan-Sarbecovirus Vaccine Clears Phase I Safety Bar, Stirs Broad Coronavirus Antibodies https://thevitalrecord.ai/2026/06/11/giredestrant-priority-review-breast-cancer/ The Vital Record en 2026-06-11T00:00:00.000Z FDA Accepts Giredestrant NDA Under Priority Review for Early ER+ Breast Cancer — Decision Due November 30 https://thevitalrecord.ai/2026/06/11/nellcor-nell-eq-skin-tone-pulse-ox/ The Vital Record en 2026-06-11T00:00:00.000Z FDA Clears Medtronic's Nellcor Nell-EQ Pulse Oximeter Under New Skin-Tone Equity Standard https://thevitalrecord.ai/2026/06/11/parabilis-670m-ipo-wnt-pathway/ The Vital Record en 2026-06-11T00:00:00.000Z Parabilis Medicines Prices Record $670M Biotech IPO; Regeneron Takes $75M Concurrent Stake